Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
fractionated RT
RADIATION
2 trials
Sponsors
EMD Serono Research & Development Institute, Inc.
, Heidelberg University
Conditions
Advanced Solid Tumors
Vertebral Bony Metastases
Phase 1
Phase 1 Trial of MSC2490484A, an Inhibitor of a DNA-dependent Protein Kinase, in Combination With Radiotherapy
Completed
NCT02516813
EMD Serono Research & Development Institute, Inc.
Advanced Solid Tumors
Start: 2015-09-15
End: 2021-11-19
Updated: 2024-10-15
Phase 2
Image-guided and Intensity-modulated Radiotherapy Versus External Beam Radiotherapy for Patients With Spine Metastases
NCT02832830
Heidelberg University
Vertebral Bony Metastases
Start: 2016-08-31
End: 2020-01-31
Target: 60
Updated: 2016-07-14
Related Papers
A Phase Ib Study of the DNA-PK Inhibitor Peposertib Combined with Neoadjuvant Chemoradiation in Patients with Locally Advanced Rectal Cancer
Clinical Cancer Research
2023-12-05
28 citations
Phase I crossover study of DNA‐protein kinase inhibitor peposertib in healthy volunteers: Effect of food and pharmacokinetics of an oral suspension
Clinical and Translational Science
2023-10-31
3 citations
A first-in-man phase 1 study of the DNA-dependent protein kinase inhibitor peposertib (formerly M3814) in patients with advanced solid tumours
British Journal of Cancer
2020-11-24
117 citations
Bone density and pain response following intensity-modulated radiotherapy versus three-dimensional conformal radiotherapy for vertebral metastases - secondary results of a randomized trial.
2018-10-30
18 citations
Quality of Life and Radiation-induced Late Toxicity Following Intensity-modulated <i>Versus</i> Three-dimensional Conformal Radiotherapy for Patients with Spinal Bone Metastases: Results of a Randomized Trial.
2018-08-01
11 citations
A phase Ia/Ib trial of the DNA-PK inhibitor M3814 in combination with radiotherapy (RT) in patients (pts) with advanced solid tumors: Dose-escalation results.
Journal of Clinical Oncology
2018-05-20
18 citations
A phase Ia/Ib trial of the DNA-dependent protein kinase inhibitor (DNA-PKi) M3814 in combination with radiotherapy in patients with advanced solid tumors.
Journal of Clinical Oncology
2017-05-20
6 citations
Radiation-induced toxicity after image-guided and intensity-modulated radiotherapy versus external beam radiotherapy for patients with spinal bone metastases (IRON-1): a study protocol for a randomized controlled pilot trial.
2017-03-03
3 citations